Trial Profile
A post marketing surveillance looking at safety of Rapamune (sirolimus) in Indian population undegoing de novo renal transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2007
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 14 Nov 2005 New trial record.